This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Mar;4(3):227-35.

doi: 10.1038/nrc1300.

Cancer as a robust system: implications for anticancer therapy

Hiroaki Kitano¹

Affiliations

PMID: 14993904
DOI: 10.1038/nrc1300

Review

Cancer as a robust system: implications for anticancer therapy

Hiroaki Kitano. Nat Rev Cancer. 2004 Mar.

. 2004 Mar;4(3):227-35.

doi: 10.1038/nrc1300.

Author

Hiroaki Kitano¹

Affiliation

¹ Sony Computer Science Laboratories, Inc., 3-14-13 Higashi-Gotanda, Shinagawa, Tokyo 141-0022, Japan. kitano@csl.sony.co.jp

PMID: 14993904
DOI: 10.1038/nrc1300

No abstract available

PubMed Disclaimer

Similar articles

Anticancer therapy-induced adverse events: practicing damage control.
Lacouture ME, Lenihan D, Wu S. Lacouture ME, et al. Expert Opin Drug Saf. 2012 May;11 Suppl 1:S1-3. doi: 10.1517/14740338.2012.669371. Expert Opin Drug Saf. 2012. PMID: 22409299 No abstract available.
Anticancer drugs.
Reese DM. Reese DM. Nature. 1995 Dec 7;378(6557):532. doi: 10.1038/378532c0. Nature. 1995. PMID: 8524372 No abstract available.
Molecular imaging as a tool for personalized and targeted anticancer therapy.
McLarty K, Reilly RM. McLarty K, et al. Clin Pharmacol Ther. 2007 Mar;81(3):420-4. doi: 10.1038/sj.clpt.6100096. Clin Pharmacol Ther. 2007. PMID: 17339871 Review. No abstract available.
Polymer conjugates as anticancer nanomedicines.
Duncan R. Duncan R. Nat Rev Cancer. 2006 Sep;6(9):688-701. doi: 10.1038/nrc1958. Epub 2006 Aug 10. Nat Rev Cancer. 2006. PMID: 16900224 Review.
Targeted therapeutics and implications for pathologists.
Geyer SJ, Johnson PC. Geyer SJ, et al. Am J Clin Pathol. 2002 Jul;118(1):144; author reply 144. Am J Clin Pathol. 2002. PMID: 12109849 No abstract available.

See all similar articles

Cited by

Disturbance of redox status enhances radiosensitivity of hepatocellular carcinoma.
Sun C, Wang ZH, Liu XX, Yang LN, Wang Y, Liu Y, Mao AH, Liu YY, Zhou X, Di CX, Gan L, Zhang H. Sun C, et al. Am J Cancer Res. 2015 Mar 15;5(4):1368-81. eCollection 2015. Am J Cancer Res. 2015. PMID: 26101703 Free PMC article.
EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model.
Tandon M, Vemula SV, Sharma A, Ahi YS, Mittal S, Bangari DS, Mittal SK. Tandon M, et al. J Gene Med. 2012 Feb;14(2):77-89. doi: 10.1002/jgm.1649. J Gene Med. 2012. PMID: 22228563 Free PMC article.
Modulating the dynamics of NFκB and PI3K enhances the ensemble-level TNFR1 signaling mediated apoptotic response.
Sherekar S, Todankar CS, Viswanathan GA. Sherekar S, et al. NPJ Syst Biol Appl. 2023 Nov 16;9(1):57. doi: 10.1038/s41540-023-00318-0. NPJ Syst Biol Appl. 2023. PMID: 37973854 Free PMC article.
New measurement methods of network robustness and response ability via microarray data.
Tu CT, Chen BS. Tu CT, et al. PLoS One. 2013;8(1):e55230. doi: 10.1371/journal.pone.0055230. Epub 2013 Jan 28. PLoS One. 2013. PMID: 23383119 Free PMC article.
Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib.
Taniguchi K, Okami J, Kodama K, Higashiyama M, Kato K. Taniguchi K, et al. Cancer Sci. 2008 May;99(5):929-35. doi: 10.1111/j.1349-7006.2008.00782.x. Epub 2008 Mar 4. Cancer Sci. 2008. PMID: 18325048 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database